Revenue (Disaggregation of Revenue by Geographical Region) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 7,167	$ 7,688
Recurring revenue
Disaggregation of Revenue [Line Items]
Revenue	5,386	5,898
Nonrecurring revenue
Disaggregation of Revenue [Line Items]
Revenue	1,781	1,790
North America
Disaggregation of Revenue [Line Items]
Revenue	3,022	3,354
Western Europe
Disaggregation of Revenue [Line Items]
Revenue	1,708	1,828
Other developed markets
Disaggregation of Revenue [Line Items]
Revenue	353	378
High-growth markets
Disaggregation of Revenue [Line Items]
Revenue	2,084	2,128
Environmental & Applied Solutions
Disaggregation of Revenue [Line Items]
Revenue			$ 4,800
Operating segments | Biotechnology
Disaggregation of Revenue [Line Items]
Revenue	1,864	2,216
Operating segments | Biotechnology | Recurring revenue
Disaggregation of Revenue [Line Items]
Revenue	1,511	1,801
Operating segments | Biotechnology | Nonrecurring revenue
Disaggregation of Revenue [Line Items]
Revenue	353	415
Operating segments | Biotechnology | North America
Disaggregation of Revenue [Line Items]
Revenue	618	782
Operating segments | Biotechnology | Western Europe
Disaggregation of Revenue [Line Items]
Revenue	647	707
Operating segments | Biotechnology | Other developed markets
Disaggregation of Revenue [Line Items]
Revenue	79	85
Operating segments | Biotechnology | High-growth markets
Disaggregation of Revenue [Line Items]
Revenue	520	642
Operating segments | Life Sciences
Disaggregation of Revenue [Line Items]
Revenue	1,709	1,666
Operating segments | Life Sciences | Recurring revenue
Disaggregation of Revenue [Line Items]
Revenue	1,039	1,037
Operating segments | Life Sciences | Nonrecurring revenue
Disaggregation of Revenue [Line Items]
Revenue	670	629
Operating segments | Life Sciences | North America
Disaggregation of Revenue [Line Items]
Revenue	708	738
Operating segments | Life Sciences | Western Europe
Disaggregation of Revenue [Line Items]
Revenue	364	328
Operating segments | Life Sciences | Other developed markets
Disaggregation of Revenue [Line Items]
Revenue	128	137
Operating segments | Life Sciences | High-growth markets
Disaggregation of Revenue [Line Items]
Revenue	509	463
Operating segments | Diagnostics
Disaggregation of Revenue [Line Items]
Revenue	2,376	2,644
Operating segments | Diagnostics | Recurring revenue
Disaggregation of Revenue [Line Items]
Revenue	2,112	2,370
Operating segments | Diagnostics | Nonrecurring revenue
Disaggregation of Revenue [Line Items]
Revenue	264	274
Operating segments | Diagnostics | North America
Disaggregation of Revenue [Line Items]
Revenue	1,124	1,306
Operating segments | Diagnostics | Western Europe
Disaggregation of Revenue [Line Items]
Revenue	420	524
Operating segments | Diagnostics | Other developed markets
Disaggregation of Revenue [Line Items]
Revenue	117	124
Operating segments | Diagnostics | High-growth markets
Disaggregation of Revenue [Line Items]
Revenue	715	690
Operating segments | Environmental & Applied Solutions
Disaggregation of Revenue [Line Items]
Revenue	1,218	1,162
Operating segments | Environmental & Applied Solutions | Recurring revenue
Disaggregation of Revenue [Line Items]
Revenue	724	690
Operating segments | Environmental & Applied Solutions | Nonrecurring revenue
Disaggregation of Revenue [Line Items]
Revenue	494	472
Operating segments | Environmental & Applied Solutions | North America
Disaggregation of Revenue [Line Items]
Revenue	572	528
Operating segments | Environmental & Applied Solutions | Western Europe
Disaggregation of Revenue [Line Items]
Revenue	277	269
Operating segments | Environmental & Applied Solutions | Other developed markets
Disaggregation of Revenue [Line Items]
Revenue	29	32
Operating segments | Environmental & Applied Solutions | High-growth markets
Disaggregation of Revenue [Line Items]
Revenue	$ 340	$ 333